JAK1 drugs for Atopic Dermatitis

7 tracked JAK1 drugs in the Atopic Dermatitis race. The class explanation lives on the JAK1 page; the full indication pipeline across every mechanism is on the Atopic Dermatitis page.

2 approved / phase 43 Phase 32 Phase 2

Head-to-head evidence: IN-115314 vs LW402 · IN-115314 vs Zemprocitinib · abrocitinib vs IN-115314 · IN-115314 vs upadacitinib · JYP0061 vs LW402 · JYP0061 vs Zemprocitinib

The roster

← all JAK1 drugs